Reaction
Sickle Cell Disease reporting signals
As of the last recalculation, Sickle Cell Disease appears in 454 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is VOXELOTOR (PRR 576.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Voxelotor | 174 | 576.0 | 580.5 |
| Hydroxyurea | 41 | 97.6 | 97.8 |
| Deferasirox | 47 | 90.5 | 90.7 |
| Zidovudine | 13 | 45.9 | 45.9 |
| Lamivudine Oral | 14 | 26.1 | 26.2 |
| Efavirenz | 6 | 25.0 | 25.0 |
| Riociguat | 17 | 24.8 | 24.8 |
| Selexipag | 13 | 23.7 | 23.7 |
| Patiromer | 3 | 10.0 | 10.0 |